Difference between revisions of "Gajjar A, et al. Clin. Cancer Res. (2013) cited as Ref 605 in DOI: 10.1038/s41392-020-0110-5 (Q9868)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1158/1078-0432.CCR-13-1425, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: Page(s) (P105): 6305-6312, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (5 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 24077351 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2013
| ||||||||||||||
| Property / Publication Date: 2013 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Clin. Cancer Res. | ||||||||||||||
| Property / Published In Name String: Clin. Cancer Res. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 19 | ||||||||||||||
| Property / Volume: 19 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study (English) | ||||||||||||||
| Property / title: Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 6305-6312 | ||||||||||||||
| Property / Page(s): 6305-6312 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:46, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Gajjar A, et al. Clin. Cancer Res. (2013) cited as Ref 605 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Gajjar A
0 references
2013
0 references
Clin. Cancer Res.
0 references
19
0 references
Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study (English)
0 references
6305-6312
0 references
